Search

everythinglearnresearchcommunity

for

Search:↓

The painting of an 18th-century Sicilian baroness shows she had hair loss, possibly due to ovarian issues, insulin resistance, or a specific type of tumor.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Oxytocin receptors are found in skin cells near touch and pain neurons.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Tianma Gouteng decoction may help prevent hair loss and promote hair growth.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Aromatase inhibitors cause male pattern hair loss in women.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.